Downloads: 2 | Views: 42 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Review Papers | Medicine | Brazil | Volume 12 Issue 8, August 2023
Clomiphene Citrate in Obesity - Associated Hypogonadism
Mateus Andrade Misson | Carlos Oliveira Leal Neto | Lucas Querino Wirz | Daniel Martins Borges  | Thalita Leal Leite Pimenta
Abstract: This study investigates the benefits of Clomiphene Citrate CC in treating obesity-associated secondary hypogonadism. An integrative review was conducted, focusing on pharmacodynamic principles, risk-benefit, safety, and therapeutic effectiveness. The study concludes that CC is a safe and effective therapy for hypogonadotropic hypogonadism, especially beneficial for those desiring fatherhood.
Keywords: Hypogonadism. Male Obesity, ClomiphenCitrat. Fertility, Hypothalamic-Pituitary-Gonadal Axis
Edition: Volume 12 Issue 8, August 2023,
Pages: 61 - 66